Changeflow GovPing Pharma & Drug Safety L'OREAL UV Emulsion Patent with Physical UV-Abs...
Routine Notice Added Final

L'OREAL UV Emulsion Patent with Physical UV-Absorbing System

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published L'OREAL's patent application US20260096965A1 for emulsion compositions containing a UV-absorbing system with physical UV-attenuating material and spherical plus amorphous particulate materials. The patent covers methods of making and using such compositions for UV protection. The application was filed October 4, 2024.

What changed

USPTO published L'OREAL's patent application (US20260096965A1) for UV emulsion compositions featuring a dual-component UV-absorbing system combining physical UV-attenuating materials with both spherical and amorphous particulate materials. The compositions are designed for topical application with enhanced UV protection properties.

Cosmetics, personal care, and sunscreen manufacturers should monitor this patent grant for potential freedom-to-operate implications or licensing opportunities. Competitors developing similar UV-protective emulsion formulations may need to design around these claims or seek licenses from L'OREAL.

What to do next

  1. Monitor for patent grant and assess formulation implications
  2. Review patent claims for potential licensing considerations

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Emulsion Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Particulate Material

Application US20260096965A1 Kind: A1 Apr 09, 2026

Assignee

L'OREAL

Inventors

ZACHARY MARON

Abstract

The present disclosure relates to emulsion compositions including a UV absorbing system (component) including at least one physical ultraviolet (UV)-attenuating material and a particulate portion (component) including at least one substantially spherical particulate material and at least one amorphous particulate material, as well as to methods of making and using such compositions.

CPC Classifications

A61K 8/27 A61K 8/06 A61K 8/25 A61K 8/29 A61Q 17/04 A61K 2800/413 A61K 2800/623

Filing Date

2024-10-04

Application No.

18906505

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
October 4th, 2024
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260096965A1

Who this affects

Applies to
Manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing UV protection formulations Cosmetic compositions
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Consumer Protection Product Safety

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.